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APPENDIX O Discounted outcomes for 65-year-old male with a 12.5% 10-year CVD risk APPENDIX P. LIFE EXPECTANCY CALCULATIONS APPENDIX Q.. SENSITIVITY ANALYSIS: Discounted outcomes for an intervention achieving a given relative risk reduction sustained over 10 years (all background risks INCREASED by 5%) APPENDIX R SENSITIVITY ANALYSIS: Discounted outcomes for an intervention achieving a given relative risk reduction sustained over 10 years (all background risks multiplied by 1.5) APPENDIX S SENSITIVITY ANALYSIS: Discounted outcomes for an intervention achieving a given relative risk reduction sustained over 10 years (all background risks REDUCED by 5%) APPENDIX T SENSITIVITY ANALYSIS: Discounted outcomes for an intervention achieving a given relative risk reduction sustained over 10 years (all background risks multiplied by 0.5, ie halved) APPENDIX U Principles of the ScHARR model incorporated into this modelling. The intervention is assumed to have a relative risk of 0.9 for each of the 10 years modelled. Column A simply shows the age at the start of each year. Column B gives the risk of other causes death in the year, defined as the probability of other causes death conditional on survival to the start of the year. Yearly all-cause death rates have been adjusted for the proportion of CVD deaths to obtain this estimate. Column C is the assumed risk profile in the absence of an intervention, so that (for example) someone who has survived to age 70 without a CVD event has a probability of 0.01412 of a first CVD event in the next year. This is obtained from applying the algorithm of Anderson et al (1991) . Column D gives the probability of CVD-free survival to the end of each year. It is calculated by a formula such as 
Unstable
Thus a known life expectancy can be approximated by an annual risk equal to the reciprocal of the life expectancy. Now suppose the individual has additional mortality  in the first year and ν in subsequent years. Then the life expectancy can be approximated as
so the life expectancy can be approximated by
This is the formula used to estimate the life expectancy following a particular CVD event.
For discounted life expectancy, note that applying an annual discount rate of  effectively multiplies the value of survival at time t by . The approximations used in developing these formulae are well within the range of reasonable modelling approximations given the assumptions made in other parts of the model.
APPENDIX U

Principles of the ScHARR model incorporated into this modelling
Primary CVD events can be classified as:
 Stable angina  Unstable angina  Myocardial infarction (non fatal)  Fatal Coronary Heart Disease  Transient Ischaemic Attack  Stroke (non fatal)  Fatal CVD (excluding CHD)
The proportion of each type of event depends on age and sex.
For each type of non-fatal event, there is an additional annual mortality and an appropriate reduction in quality of life for survivors. There is also an immediate cost of treatment and an expected annual cost of maintenance therapy (including secondary prevention) for survivors.
Using data published in the ScHARR model report, we estimated the discounted quality adjusted life expectancy and lifetime costs following each type of non-fatal event, as a function of age and sex.
Comparing these with the discounted quality adjusted life expectancy in the absence of a primary CVD event, we were able to estimate the cost saving and QALY gain for each event prevented, also as a function of age and sex.
The quality of life data used in the model for each type of non-fatal event were as follows: 
